Quarterly ResultApr 29, 2026, 04:07 PM
TDOC Q1 Revenue Down 2% to $613.8M; Net Loss $63.8M
AI Summary
Teladoc Health, Inc. reported Q1 2026 financial results with revenue down 2% year-over-year to $613.8 million. The company's net loss improved by 31% to $63.8 million, or $0.36 per share, while adjusted EBITDA remained essentially flat at $58.2 million. Integrated Care segment revenue grew 2%, offsetting a 9% decline in the BetterHelp segment. Teladoc Health reaffirmed the midpoint of its full-year financial outlook for 2026.
Key Highlights
- TDOC Q1 2026 revenue decreased 2% to $613.8 million YoY.
- Net loss improved 31% to $63.8 million, or $0.36 per share.
- Adjusted EBITDA was essentially flat at $58.2 million.
- Integrated Care segment revenue increased 2% to $395.4 million.
- BetterHelp segment revenue decreased 9% to $218.4 million.
- Full-year 2026 revenue outlook reaffirmed at $2,481 - $2,576 million.
- Full-year 2026 adjusted EBITDA outlook reaffirmed at $267 - $306 million.